Sensors for Communication for Persons Who Cannot Communicate Unequivocally
Launched by UNIVERSITY OF OSLO · Dec 12, 2019
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping individuals who have difficulty communicating their feelings or needs due to conditions like intellectual disabilities, autism, or cerebral palsy. Many people in these situations cannot clearly express if they are in pain, feeling uncomfortable, or experiencing emotions like anger or fear. The researchers are testing new heart and breathing monitors that will help these individuals communicate their immediate reactions more effectively. For example, the breathing monitor will also help track sleep patterns, allowing caregivers to understand if the participants had a good night's sleep.
To be eligible for this trial, participants should be between the ages of 18 to 29 and have an intellectual disability, with or without autism and/or cerebral palsy, that makes it hard for them to communicate their needs. However, individuals with allergic skin reactions to the chest strap used for monitoring cannot participate. Those who join the study can expect to wear the monitors and share how these devices help them express their feelings and reactions better. This study aims to improve communication methods for those who struggle to be understood, making it easier for caregivers to provide the right support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • intellectual disability with or without autism and/or cerebral palsy that render the participant unable to communicate his/her needs and reactions unequivocally.
- Exclusion Criteria:
- • allergic skin reaction to chest strap
About University Of Oslo
The University of Oslo, a leading research institution in Norway, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and ethical research practices, the university harnesses its extensive expertise in various fields, including medicine, health sciences, and biomedical research. The University of Oslo actively engages in clinical trials aimed at exploring new therapies and interventions, fostering a culture of scientific inquiry, and contributing to the global understanding of health and disease. Through its commitment to excellence and rigorous methodologies, the university seeks to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Bjørnar Hassel, PhD
Principal Investigator
University of Oslo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials